Cytosine arabinoside Injection 500 mg/vial

๐Ÿ’Š Medicine Name:

Cytosine Arabinoside
(Cytarabine)

๐Ÿ’‰ Formulation:

Injection โ€“ Lyophilized powder for reconstitution, administered intravenously (IV), subcutaneously (SC), or intrathecally (for CNS use in some cases)

๐Ÿ’ช Strength:

500 mg per vial


๐Ÿ“œ Description:

Cytarabine is a chemotherapeutic antimetabolite that mimics cytosine, a natural nucleotide. It is widely used for the treatment of hematological malignancies, especially leukemias, by interfering with DNA replication in rapidly dividing cancer cells.


๐ŸŒฟ Nature:

  • Antimetabolite (pyrimidine analogue)
  • S-phase specific โ€“ acts during DNA synthesis phase
  • Cytotoxic agent โ€“ targets rapidly dividing cells
  • Used in both curative and palliative treatment regimens
  • Often combined with other drugs like anthracyclines

๐ŸŒŸ Advantages:

  • Core component in induction and consolidation chemotherapy for acute myeloid leukemia (AML)
  • Allows dose adjustment flexibility โ€“ available in multiple vial strengths (100 mg, 500 mg, 1 g)
  • Can be administered systemically or intrathecally, giving it versatility in targeting both systemic and CNS disease
  • Established role in protocols like “7+3” regimen and high-dose cytarabine (HiDAC) therapy
  • Effective even in blast crisis of CML and CNS leukemia

๐Ÿงพ Prescription:

  • Prescription-only drug (Rx)
  • Administered by trained professionals in hospital or oncology units

๐ŸŽฏ Indications / Uses:

  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Chronic Myeloid Leukemia (CML) โ€“ blast phase
  • Meningeal leukemia/lymphoma (CNS involvement)
  • Non-Hodgkinโ€™s lymphoma (selected cases)

๐Ÿ“ฆ Packaging:

  • Supplied in glass vials with sterile lyophilized powder
  • Labeled with โ€œCytotoxic โ€“ Handle with careโ€ instructions
  • Requires reconstitution with sterile water or compatible diluent
  • May be used immediately or stored for short duration as per guidelines

๐ŸงŠ Storage:

  • Store dry powder at 15โ€“25ยฐC
  • Protect from light and humidity
  • Reconstituted solution must be used within a specific time depending on storage conditions
  • Do not freeze reconstituted solution

๐Ÿ‘จโ€โš•๏ธ Patient Advice:

  • Must be administered in a controlled medical setting
  • Regular blood tests needed to monitor response and toxicity
  • May require supportive eye drops during high-dose treatment
  • Avoid contact with people having infections due to immunosuppression
  • Patients should report fever, bleeding, or unusual fatigue promptly

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button